Common biomarkers for MIPs used in cancer detection are prostate-specific antigen (PSA), HER-2 in breast cancer, CA-125 in epithelial cancer, and α-fetoprotein (AFP) in liver cancer. This evidence concerns the gene KLK3 and breast carcinoma.